Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients

OBJECTIVE: Octreotide is used to treat patients with neuroendocrine tumors. Previous reports show that octreotide long-acting repeatable (LAR) dose and patient body weight affect nadir plasma octreotide levels (approximately 1250, 2500, 5000, and 11,000 pg/mL for LAR doses of 10, 20, 30 and 60 mg/mo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Woltering, Eugene A., Salvo, Vergilio A., O'Dorisio, Thomas M., Lyons, John, Li, Gang, Zhou, Ying, Seward, Jacky R., Go, Vay Liang W., Vinik, Arthur I., Mamikunian, Paris, Mamikunian, Gregg
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2008
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2698789/
https://ncbi.nlm.nih.gov/pubmed/18580450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0b013e31816907ab
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge